Long COVID: Major Findings, Pathophysiology and Mechanisms, Risk Factors, Vaccinations, and Managements
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Diagnostic Microbiology and Infectious Disease".
Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 6600
Special Issue Editors
Interests: infection; tropical diseases; emerging infectious diseases; infectious disease diagnostics and treatment
Special Issues, Collections and Topics in MDPI journals
Interests: infection; tropical diseases; emerging infectious diseases; infectious disease diagnostics and treatment
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Most COVID-19 patients recover; but, some of them experience continued symptoms some weeks after SARS-CoV-2 infection, described as “long-COVID-19”. These individuals experience a wide set of symptoms, such as persistent fatigue, malaise, pulmonary, renal, neurological, and vascular symptoms. It is important to note, according to certain studies, that few children and young people suffer from long COVID-19. The mechanisms underlying long COVID-19 are still largely unclear. Subsequently, it is currently uncertain how one should diagnose and manage this syndrome. Some studies show that COVID-19 vaccines reduce the risk of developing long COVID-19, but it is still not quite understood. Therefore, there are several essential trending topics relating to work on long COVID-19, etc. The Special Issue aims to identify essential knowledge for researchers who study the improvement of diagnosis and treatment of long COVID-19.
Dr. Soheil Ebrahimpour
Dr. Mostafa Javanian
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- long COVID
- pathophysiology
- risk factors
- vaccinations
- diagnosis
- treatment
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.